New Business Opportunities for Science Thursday, April 26, 2007
| Unit | Technology & Operations Management > Conferences & Seminars |
|---|
Sponsored by Harvard Business School
Agenda
| Schedule | |
|---|---|
| 4:00 - 4:15 p.m. | Welcome Remarks |
| 4:15 - 5:30 p.m. |
Cross-disciplinary teams(comprised of students from the Business, Medical, Science, Engineering, Law, Government, and Public Health Schools) will present commercialization plans for university science research. The format is a poster session; each project analyzes a real and current science commercialization opportunity from the listed labs and startups. |
| Participant Teams by Project Sponsor: | |
|
(click project titles to view posters) BiotechnologyD. Fisher: "Complete Epigenetics Solution" — A novel technology to determine nucleosome locations in cell and tissue samples for development of novel pharmaceuticals and diagnostics. C. Mitsiades: "High-Throughput Mixed-Culture Screen" A novel pre-clinical screening tool for analyzing tumor sensitivity to drugs in mixed cell cultures. D. Mooney: "Controlled Cell Delivery" — Extracellular matrices to recruit, maintain and deliver cell therapies: tissue regeneration/repair to anti-cancer therapy. G. Verdine: "RIPtides" — Novel oligonucleotide-based therapeutics targeting assembly of telomerase and other medically relevant biological targets. Vertex Pharmaceuticals Inc.: "Hepatitis C Management" — Changing the patient management paradigm for transformational Hepatitis C virus treatments. G. Whitesides: "Protein Sensing" — A novel separation technique for proteomic analysis and identification of biomarkers for disease. Clean TechnologyM. Aziz: "Carbon Neutral Power" —Technology that captures and stores carbon dioxide as solid crystals making traditional power plants climate friendly. P. Girguis: "Microbial Fuel Cell" — Renewable, zero-pollution, and low cost and maintenance power sources for off-grid applications. Information TechnologyIcosystem Corp.: "The Hunch Engine Platform" — A licensable genetic algorithm for human creativity. D. Parkes: "Cryptographic Securities Exchange" — Improved method for trading financial instruments that selectively conceals vulnerable trade information. C. Kennedy: "Drug Discovery - Imaging & Informatics" — Two novel software programs for the automated analysis of neuronal morphologies to enable medical researchers to improve drug discovery. Medical DeviceC. Cutie: "Self-dilating Urethral Catheter" — Balloon-dilating catheter that patients can inflate to treat urethral strictures at home. G. Gardner: "Pericardial Device" — Pericardial support device for advanced heart failure. C. Marcus: "Molecular Imaging for MRI" — Using hyperpolarized silicon for molecular imaging. K. Parker: "Molecular Scalpel" — Re-useable test to provide real-time diagnoses and guide medical treatment decisions with molecular precision. M. Su: "Luminescence-based, Multi-metabolite Monitor" — Point of care device to optimize effective disease management. A. Tavakkolizadeh: "Transluminal Surgery" — An alternative to laparoscopic surgery using novel technique and innovative medical devices for scarless access to the abdomen. G. Whitesides: "Patterned Paper Diagnostics" — Low-cost point-of-care analysis of biological fluids: outpatient clinics to less-industrialized regions. G. Whitesides: "Spectrally Tunable Laser" — Microfluidics technology that broadens the scope of laser-based clinical treatments using wavelength tunable light. |
|